1993
DOI: 10.1016/0306-4522(93)90517-j
|View full text |Cite
|
Sign up to set email alerts
|

Time course, localization and pharmacological modulation of immediate early inducible genes, brain-derived neurotrophic factor and trkB messenger RNAs in the rat brain following photochemical stroke

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0
1

Year Published

1996
1996
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 109 publications
(26 citation statements)
references
References 48 publications
1
24
0
1
Order By: Relevance
“…The outgrowth of lesioned CST axons can be promoted by application of neurotrophic growth factors, such as vascular endothelial growth factor (VEGF) (Facchiano et al, 2002), brain-derived neurotrophic factor (BDNF) (Vavrek et al, 2006), or by knockout or neutralization of inhibitory signals such as Nogo (Schwab, 2004) and Nogo receptors (GrandPre et al, 2002). Following ischemic lesions, the adult CNS can induce cellular responses needed for neurite growth and synaptic formation (Cramer and Chopp, 2000), including the expression of growth-promoting factors, such as BDNF (Comelli et al, 1993) and basic fibroblast growth factor (bFGF) (Lin et al, 1997) that could lead to partial spontaneous functional recovery. Related studies have indicated that functional recovery in rodent ischemic stroke models is associated with collateral sprouting of the uninjured CST to the denervated side of spinal cord and is enhanced by treatment of inosine , bFGF (Kawamata et al, 1997), Nogo antibody (Papadopoulos et al, 2002) and Nogo receptor antagonist (Lee et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…The outgrowth of lesioned CST axons can be promoted by application of neurotrophic growth factors, such as vascular endothelial growth factor (VEGF) (Facchiano et al, 2002), brain-derived neurotrophic factor (BDNF) (Vavrek et al, 2006), or by knockout or neutralization of inhibitory signals such as Nogo (Schwab, 2004) and Nogo receptors (GrandPre et al, 2002). Following ischemic lesions, the adult CNS can induce cellular responses needed for neurite growth and synaptic formation (Cramer and Chopp, 2000), including the expression of growth-promoting factors, such as BDNF (Comelli et al, 1993) and basic fibroblast growth factor (bFGF) (Lin et al, 1997) that could lead to partial spontaneous functional recovery. Related studies have indicated that functional recovery in rodent ischemic stroke models is associated with collateral sprouting of the uninjured CST to the denervated side of spinal cord and is enhanced by treatment of inosine , bFGF (Kawamata et al, 1997), Nogo antibody (Papadopoulos et al, 2002) and Nogo receptor antagonist (Lee et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…In adjacent areas, the facilitation of long-term potentiation 3 and synaptic plasticity occurs, as demonstrated by a sequential increase in markers for axonal sprouting and synaptogenesis. 23 First, the expression of the growth cone marker growth-associated protein 43 24 and other growth-associated markers 25,26 has been observed in rodents between 3 and 14 days post cortical infarction and was followed by increased expression of the synapse marker synaptophysin until 60 days postinfarction. Positive signals for axonal sprouting have been found to be sequentially replaced by negative factors such as Nogo, [27][28][29] chondroitin sulfate proteoglycan, 30 ephrin-A5, semaphorin-3A, and neuropilin-1 24 to balance the initial reaction.…”
Section: Functional Considerationsmentioning
confidence: 99%
“…In animal models of stroke an increase in the levels of BDNF mRNA is observed, starting approximately two hours after stroke commencement. 82 The mRNA was observed predominantly in cells which have normal morphological appearance. 82 Subsequent studies showed that administration of BDNF via an osmotic pump directly into the infarct following middle cerebral artery occlusion (MCAO), could lead to a significant reduction in infarct size.…”
Section: Vector-mediated Transportmentioning
confidence: 99%
“…82 The mRNA was observed predominantly in cells which have normal morphological appearance. 82 Subsequent studies showed that administration of BDNF via an osmotic pump directly into the infarct following middle cerebral artery occlusion (MCAO), could lead to a significant reduction in infarct size. 83 Studies in single allele BDNF knockout mice confirmed these findings.…”
Section: Vector-mediated Transportmentioning
confidence: 99%